PCCA Listed by nitrogen Ransomware Group: Ransomware Claim — What’s Alleged & What To Do
The PCCA Listed by nitrogen Ransomware Group (reported March 29, 2023) is an unverified claim; the data involved is undisclosed belonging to roughly unknown people. If you have an account with them, your information may now be circulating on the open web and with data brokers. Here’s exactly what happened, how to check if you were affected, and what to do next.
On March 29, 2023, the organization known as PCCA was listed by the ransomware group nitrogen. Public reporting indicates that internal files were exfiltrated in a ransomware attack, though the number of people affected remains unknown and further specifics about the incident have not been disclosed. The listing itself constitutes a claim by the group rather than independently confirmed detail.
PCCA works in personalized medicine, innovative products, and pharmaceutical compounding. A breach involving an organization in this sector raises clear questions about the security of internal operational material and any associated records, even when the precise scope stays limited in public accounts.
What happened
According to available reporting, PCCA appeared on a listing associated with the nitrogen ransomware group on March 29, 2023. The incident is described as a ransomware attack in which internal files were allegedly exfiltrated. No public figure has been given for the number of individuals affected, and details such as the precise method of intrusion, the duration of unauthorized access, the volume of data taken, or any ransom demand remain undisclosed.
The group's leak-site listing is treated here as an unverified claim. No confirmation of the full extent of the compromise, or of any subsequent data publication, appears in the reported facts. Timing beyond the March 29, 2023 report date is not provided.
Who is nitrogen?
Nitrogen is a ransomware operation that has been observed in public reporting as using double-extortion tactics: encrypting systems while also claiming to steal data and threatening to release it if demands are not met. Like other groups in this category, it has typically advertised victims on dedicated leak sites to apply pressure. Public documentation of the group describes standard ransomware behaviors such as initial access through common vectors, lateral movement, and data theft prior to encryption, though specific tooling and affiliates can vary across incidents.
No statements attributed to nitrogen about PCCA beyond the act of listing the organization are included in the facts of this case. Claims made on leak sites are assertions by the actors themselves and are not independently verified here. Prior activity by the group is a matter of broader public record concerning ransomware ecosystems, not evidence particular to this victim.
About PCCA
PCCA supports the creation of personalized medicine and innovative products, as well as pharmaceutical compounding. Organizations of this type operate at the intersection of pharmacy practice, custom formulation, and supply of materials or expertise used to prepare tailored medications. They commonly maintain relationships with compounding pharmacies, clinicians, and related partners, and they handle operational, technical, and sometimes regulated information tied to product development and distribution.
A breach affecting such an entity is consequential because the sector deals with materials and processes that can touch patient care pathways, proprietary formulations, and business records. Even when only "internal files" are named, the nature of the work means those files may intersect with sensitive operational or partner data. Public detail does not establish exactly which systems or records were involved in this incident.
What was likely exposed
The facts state that internal files were exfiltrated in a ransomware attack. No further breakdown of data types—such as employee records, customer or partner information, financial documents, intellectual property, or clinical-related material—has been disclosed. The number of people affected is unknown.
Organizations engaged in pharmaceutical compounding and personalized-medicine support typically hold a range of internal material: business correspondence, operational procedures, supplier and customer details, research or formulation notes, and administrative records. Some of that material can include personal data or commercially sensitive information. Because the exact contents taken in this case are unconfirmed, it is not possible to state what specific categories were exposed. Any assumption that particular data sets were or were not involved would go beyond the reported facts.
Why it matters
For individuals whose information may have been present in internal files, the practical risks include potential misuse of personal or contact details, targeted phishing that references the organization, or broader identity-related harm if identifiers were included. These outcomes are not guaranteed; they depend on what was actually taken and whether it is ever misused. For partners, pharmacies, or other entities that work with PCCA, exposure of contractual, technical, or operational files could create secondary operational or competitive concerns.
For the organization itself, a ransomware incident with claimed exfiltration can disrupt operations, trigger regulatory and notification obligations where personal data is involved, and require sustained recovery and review work. Because the scale and precise data types remain undisclosed, the full real-world impact cannot be quantified from public information alone. The episode underscores the value of monitoring for abuse of any credentials or personal details that might have been stored in internal systems, without presuming negligence or assigning fault as established fact.
If your data was in this claimed breach
If you have a relationship with PCCA—as an employee, partner, customer, or in another capacity—consider practical steps. Monitor financial and account statements for unusual activity. Treat unsolicited messages that reference the organization or the incident with caution, and verify any request for personal information through known official channels. Change passwords on related accounts if you reuse credentials, and enable multi-factor authentication where available. If you believe sensitive personal data may have been involved, you may also wish to review credit reports or place fraud alerts according to the options available in your jurisdiction.
Public detail on this incident does not confirm who was affected. Readers can run a free exposure scan of their email address to check whether their information has already surfaced in known breach data sets, which may provide an additional point of reference alongside any direct notifications they receive.
AICompiled with AI assistance from public sources and published under our editorial standards.
How this breach connects
More recent breaches
LumioDental Listed by nitrogen Ransomware GroupPyramid Listed by nitrogen Ransomware GroupDeWalch Technologies, Inc Listed by nitrogen Ransomware GroupConnor Co Listed by nitrogen Ransomware GroupLatest breaches
Read GalaxyWarden’s full analysis of the PCCA Listed by nitrogen Ransomware Group →
Publicly posted by nitrogen — unverified claim, pending independent verification
Breach listings — particularly those originating from ransomware or leak sites — are third-party claims that may be unverified, incomplete, or inaccurate. A listing does not by itself confirm that a breach occurred or that any specific data was exposed. Severity is an automated assessment, not a definitive rating. Verification status is shown where available.
Attributions to threat groups and methods reflect public reporting and, in some cases, unverified claims made by the groups themselves; they may be incomplete or later revised. Recent Breaches and GalaxyWarden are independent and are not affiliated with, and do not endorse, any company or group named on this page. This information is aggregated from public sources for awareness only and is not legal, security, or investment advice.